Rentosertib and the Dawn of a New Era in AI-Driven Drug Discovery (opens in new tab)

For years, the promise of artificial intelligence in drug discovery has lived mostly in press releases and conference decks. Researchers have talked about what AI could do — compress timelines, identify overlooked targets, and design better molecules. What we haven’t seen much of, until now, is an AI-designed drug actually walking through clinical trials with […] The post Rentosertib and the Dawn of a New Era in AI-Driven Drug Discovery appeared first on CBIRT.